Cyclosporin Impurity 5

Cyclosporin Impurity 5

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Cyclosporin Impurity 5
Category Cyclosporin Analogue Set
Catalog number BBF-05761
CAS 437611-17-1
Molecular Weight 1188.58
Molecular Formula C61H109N11O12
Purity ≥95%

Online Inquiry

Description

Cyclosporin Impurity 5 is an impurity of cyclosporin, which is a calcineurin phosphatase pathway inhibitor, used as an immunosuppressant drug to prevent rejection in organ transplantation.

Specification

Synonyms 10-[(2S)-2-Aminobutanoic acid]cyclosporin A; Cyclosporin A, 10-[(2S)-2-aminobutanoic acid]-; [Abu5]cyclosporin; cyclo[Abu-Sar-N(Me)Leu-Abu-N(Me)Leu-Ala-D-Ala-N(Me)Leu-N(Me)Leu-N(Me)Val-N(Me)Bmt(E)]; cyclo[(N-(((2S)-2-aminobutyryl)-sarcosyl-N-methyl-L-leucyl)-(2S)-2-aminobutyryl)-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-N-methyl-(4R)-4-[(E)-but-2-enyl]-4-methyl-L-threonyl]; (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-21,30-diethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18,24-tetraisobutyl-3-isopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
IUPAC Name (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-21,30-diethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
Canonical SMILES CCC1C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)N1)CC(C)C)C)C)CC)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C
InChI InChI=1S/C61H109N11O12/c1-24-27-28-39(14)51(74)50-55(78)65-42(25-2)57(80)66(17)33-48(73)67(18)44(29-34(4)5)54(77)64-43(26-3)58(81)68(19)45(30-35(6)7)53(76)62-40(15)52(75)63-41(16)56(79)69(20)46(31-36(8)9)59(82)70(21)47(32-37(10)11)60(83)71(22)49(38(12)13)61(84)72(50)23/h24,27,34-47,49-51,74H,25-26,28-33H2,1-23H3,(H,62,76)(H,63,75)(H,64,77)(H,65,78)/b27-24+/t39-,40+,41-,42+,43+,44+,45+,46+,47+,49+,50+,51-/m1/s1
InChI Key IPDSMZFDGQKXHO-AYGVNIPJSA-N

Properties

Boiling Point 1293.0±65.0°C at 760 mmHg
Density 1.016±0.06 g/cm3

Reference Reading

1. Stability of cyclosporine solutions stored in polypropylene-polyolefin bags and polypropylene syringes
Mengqing Li, Jean-Marc Forest, Christian Coursol, Grégoire Leclair Am J Health Syst Pharm. 2011 Sep 1;68(17):1646-50. doi: 10.2146/ajhp100445.
Purpose: The stability of cyclosporine diluted to 0.2 or 2.5 mg/mL with 0.9% sodium chloride injection or 5% dextrose injection and stored in polypropylene-polyolefin containers or polypropylene syringes was evaluated. Methods: Intravenous cyclosporine solutions (0.2 and 2.5 mg/mL) were aseptically prepared and transferred to 250-mL polypropylene-polyolefin bags or 60-mL polypropylene syringes. Chemical stability was measured using a stability-indicating high-performance liquid chromatography (HPLC) assay. Physical stability was assessed by visual inspection and a dynamic light scattering (DLS) method. Results: After 14 days, HPLC assay showed that the samples of i.v. cyclosporine stored in polypropylene-polyolefin bags remained chemically stable (>98% of initial amount remaining); the physical stability of the samples was confirmed by DLS and visual inspection. The samples stored in polypropylene syringes were found to contain an impurity (attributed to leaching of a syringe component by the solution) that could be detected by HPLC after 1 day; on further investigation, no leaching was detected when the syringes were exposed to undiluted i.v. cyclosporine 50 mg/mL for 10 minutes. Conclusion: Samples of i.v. cyclosporine solutions of 0.2 and 2.5 mg/mL diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored at 25 °C in polypropylene-polyolefin bags were physically and chemically stable for at least 14 days. When stored in polypropylene syringes, the samples were contaminated by an impurity within 1 day; however, the short-term (i.e., ≤10 minutes) use of the syringes for the preparation and transfer of i.v. cyclosporine solution is considered safe.
2. Purification of a modified cyclosporine A by co-current centrifugal partition chromatography: process development and intensification
Nassima Amarouche, Leslie Boudesocque, Charlotte Sayagh, Matthieu Giraud, John McGarrity, Alessandro Butte, Luc Marchal, Alain Foucault, Jean-Hugues Renault J Chromatogr A. 2013 Oct 11;1311:72-8. doi: 10.1016/j.chroma.2013.08.053. Epub 2013 Aug 21.
Synthetic hydrophobic non-ionizable peptides are not soluble in most common solvents and are thus difficult to purify by preparative reversed-phase HPLC, normally used for industrial production. The challenge exists to develop alternative purification chromatographic processes using suitable solvents and providing good yields, high purity and sufficient productivity. A 11mer hydrophobic synthetic modified cyclosporine, showing an anti-HIV activity, was successfully purified by centrifugal partition chromatography using the biphasic solvent system heptane/ethyl acetate/acetone/methanol/water (1:2:2:1:2, v/v). A 5% co-current elution - made possible by the liquid nature of the two phases - has been used in order to avoid hydrodynamic instabilities mainly due to the physico-chemical properties of the target peptide. This original solution was developed after the study of the effect of the peptide on the hydrodynamic behavior of the two phases during the separation, and the visualization of the flow patterns using the Visual-CPC device. Critical impurities were efficiently eliminated and the peptide was recovered in high yield and high productivity achieving the specifications requirements.
3. [Adsorption, separation, and purification of cyclosporine A using reversed-phase liquid chromatography]
Zhidong Li, Qing Fu, Zhuoshun Dai, Yu Jin, Xinmiao Liang Se Pu. 2022 Jan;40(1):66-73. doi: 10.3724/SP.J.1123.2021.01045.
High performance liquid chromatography (HPLC) is widely used in the separation and analysis of cyclosporine A (CsA). Analyzing the chromatographic behavior of CsA is key to the purification of CsA by preparative HPLC. In this study, the retention behavior of CsA on the C18 column using mobile phases of methanol-water and acetonitrile-water was compared. The retention time of CsA was sensitive to the change in the ratio of the organic solvent. When 84%-88% methanol or 75%-85% acetonitrile was used, the retention factor (k) was in the range of 3-7. The change in the peak shape of CsA was investigated with loading amounts of 5, 25, 50, 100, and 500 mg. With an increase in sample loading, the peak shape of CsA in both mobile phases changed from symmetric to tailing, and the retention time reduced. Therefore, it is necessary to focus on the removal of impurities that were eluted before CsA during the purification. In addition, the peak shapes of CsA in methanol-water and acetonitrile-water were similar in the tested concentration range. This indicates that it was not possible to tune the peak shape of CsA by changing the organic solvent. Adsorption isotherms were obtained to describe the retention behavior of CsA. When the mass concentration of CsA in the mobile phase was low, the effect of the organic solvent ratio on the adsorption capacity of CsA on the C18 stationary phase was not distinct. With an increase in the solute mass concentration above 0.5 g/L, the reduced proportion of organic solvent helped improve the adsorption capacity of CsA. When the mass concentration of CsA in the mobile phase reached 5 g/L, the adsorption capacities were 24.9 g/L in 88% methanol and 40.8 g/L in 84% methanol. The adsorption capacity of CsA in acetonitrile-water was higher than that in methanol-water. When the mass concentration of CsA was 5 g/L, the adsorption capacity increased to 46.4 g/L in 75% acetonitrile. Scatchard analysis showed that the slope of the adsorption isotherm decreased gradually, which was consistent with trend observed in the Langmuir adsorption isotherm for the shape of the Langmuir peak (i.e. trailing peak). When the mass concentration of CsA in the mobile phase was between 0.01 g/L and 0.03 g/L, the slope of the curve decreased significantly, and the peak shape of CsA rapidly tailed with increasing loading amount. However, when using a mobile phase with a lower proportion of organic solvent (84% methanol or 75% acetonitrile), this trend was weakened. The adsorption data of CsA were fitted to models. The Langmuir model was found to be suitable for the methanol-water mobile phase, and the Moreau model for the acetonitrile-water mobile phase. The model parameters indicated that the monolayer adsorption of CsA occurred on the C18 stationary phase in both mobile phases, the difference being that more intermolecular interactions between CsA occurred in the acetonitrile-water mobile phase, resulting in a higher adsorption capacity. In methanol-water, the intermolecular interactions between CsA were inhibited by methanol due to its role as a proton donor. As an aprotic solvent, acetonitrile could only weakly inhibit these interactions; hence, the interactions could be improved by increasing the acetonitrile proportion. As the proportion of acetonitrile changed from 85% to 75%, the saturated adsorption capacity increased from 123 g/L to 197 g/L, while the interaction constant decreased from 0.618 to 0.588. Finally, CsA was purified using the conditions of 0-60 min 65%-75% acetonitrile, 60-80 min 75% acetonitrile, by which the impurity could be controlled to below 0.2%. The results of this study will aid in the purification of CsA by preparative HPLC.

Recommended Products

Bio Calculators

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Recently viewed products

Online Inquiry

Verification code
cartIcon
Inquiry Basket